• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

动脉导管与中心静脉导管相关的感染风险比较。

Infectious risk associated with arterial catheters compared with central venous catheters.

机构信息

Head of Infection Control Unit, Bichat-Claude Bernard University Hospital, Assistance publique-hôpitaux de Paris, Paris.

出版信息

Crit Care Med. 2010 Apr;38(4):1030-5. doi: 10.1097/CCM.0b013e3181d4502e.

DOI:10.1097/CCM.0b013e3181d4502e
PMID:20154601
Abstract

BACKGROUND

Scheduled replacement of central venous catheters and, by extension, arterial catheters, is not recommended because the daily risk of catheter-related infection is considered constant over time after the first catheter days. Arterial catheters are considered at lower risk for catheter-related infection than central venous catheters in the absence of conclusive evidence.

OBJECTIVES

To compare the daily risk and risk factors for colonization and catheter-related infection between arterial catheters and central venous catheters.

METHODS

We used data from a trial of seven intensive care units evaluating different dressing change intervals and a chlorhexidine-impregnated sponge. We determined the daily hazard rate and identified risk factors for colonization using a marginal Cox model for clustered data.

RESULTS

We included 3532 catheters and 27,541 catheter-days. Colonization rates did not differ between arterial catheters and central venous catheters (7.9% [11.4/1000 catheter-days] and 9.6% [11.1/1000 catheter-days], respectively). Arterial catheter and central venous catheter catheter-related infection rates were 0.68% (1.0/1000 catheter-days) and 0.94% (1.09/1000 catheter-days), respectively. The daily hazard rate for colonization increased steadily over time for arterial catheters (p = .008) but remained stable for central venous catheters. Independent risk factors for arterial catheter colonization were respiratory failure and femoral insertion. Independent risk factors for central venous catheter colonization were trauma or absence of septic shock at intensive care unit admission, femoral or jugular insertion, and absence of antibiotic treatment at central venous catheter insertion.

CONCLUSIONS

The risks of colonization and catheter-related infection did not differ between arterial catheters and central venous catheters, indicating that arterial catheter use should receive the same precautions as central venous catheter use. The daily risk was constant over time for central venous catheter after the fifth catheter day but increased significantly over time after the seventh day for arterial catheters. Randomized studies are needed to investigate the impact of scheduled arterial catheter replacement.

摘要

背景

不建议常规更换中心静脉导管和动脉导管,因为在首次置管后的最初几天之后,导管相关感染的每日风险被认为是恒定的。在没有确凿证据的情况下,动脉导管被认为比中心静脉导管的感染风险更低。

目的

比较动脉导管和中心静脉导管的定植和导管相关感染的每日风险及相关因素。

方法

我们使用了一项在 7 个重症监护病房中进行的试验数据,该试验评估了不同的敷料更换间隔和氯己定浸渍海绵。我们使用聚集数据的边缘 Cox 模型确定了每日危险率和定植的危险因素。

结果

我们纳入了 3532 根导管和 27541 天导管留置。动脉导管和中心静脉导管的定植率没有差异(分别为 7.9%[11.4/1000 导管天]和 9.6%[11.1/1000 导管天])。动脉导管和中心静脉导管的导管相关感染率分别为 0.68%(1.0/1000 导管天)和 0.94%(1.09/1000 导管天)。动脉导管的定植每日危险率随时间稳步增加(p=0.008),但中心静脉导管的危险率保持稳定。动脉导管定植的独立危险因素是呼吸衰竭和股动脉置管。中心静脉导管定植的独立危险因素是重症监护病房入院时创伤或无脓毒症休克、股静脉或颈内静脉置管和中心静脉导管插入时无抗生素治疗。

结论

动脉导管和中心静脉导管的定植和导管相关感染风险没有差异,这表明动脉导管的使用应与中心静脉导管的使用一样受到相同的预防措施。在首次置管后的第 5 天之后,中心静脉导管的每日风险是恒定的,但在第 7 天之后,动脉导管的每日风险显著增加。需要进行随机研究来探讨定期更换动脉导管的影响。

相似文献

1
Infectious risk associated with arterial catheters compared with central venous catheters.动脉导管与中心静脉导管相关的感染风险比较。
Crit Care Med. 2010 Apr;38(4):1030-5. doi: 10.1097/CCM.0b013e3181d4502e.
2
Comparison of Oligon catheters and chlorhexidine-impregnated sponges with standard multilumen central venous catheters for prevention of associated colonization and infections in intensive care unit patients: a multicenter, randomized, controlled study.对比寡肽导管和氯己定浸渍海绵与标准多腔中心静脉导管在预防重症监护病房患者相关定植和感染的效果:一项多中心、随机、对照研究。
Crit Care Med. 2012 Feb;40(2):420-9. doi: 10.1097/CCM.0b013e31822f0d4b.
3
Prospective study of peripheral arterial catheter infection and comparison with concurrently sited central venous catheters.外周动脉导管感染的前瞻性研究及与同期放置的中心静脉导管的比较。
Crit Care Med. 2008 Feb;36(2):397-402. doi: 10.1097/CCM.0b013e318161f74b.
4
Jugular versus femoral short-term catheterization and risk of infection in intensive care unit patients. Causal analysis of two randomized trials.颈内静脉与股静脉短期置管与 ICU 患者感染风险。两项随机试验的因果分析。
Am J Respir Crit Care Med. 2013 Nov 15;188(10):1232-9. doi: 10.1164/rccm.201303-0460OC.
5
Economic evaluation of chlorhexidine-impregnated sponges for preventing catheter-related infections in critically ill adults in the Dressing Study.《Dressing 研究:洗必泰浸渍海绵预防危重症成人导管相关感染的经济学评价》
Crit Care Med. 2012 Jan;40(1):11-7. doi: 10.1097/CCM.0b013e31822f0604.
6
Evaluating central venous catheter care in a pediatric intensive care unit.评估儿科重症监护病房中的中心静脉导管护理。
Am J Crit Care. 2009 Nov;18(6):514-20; quiz 521. doi: 10.4037/ajcc2009168.
7
Efficacy of antiseptic-impregnated catheters on catheter colonization and catheter-related bloodstream infections in patients in an intensive care unit.抗菌浸渍导管对重症监护病房患者导管定植及导管相关血流感染的疗效
J Hosp Infect. 2006 Feb;62(2):156-62. doi: 10.1016/j.jhin.2005.06.030. Epub 2005 Nov 22.
8
A prospective, randomized trial of rifampicin-minocycline-coated and silver-platinum-carbon-impregnated central venous catheters.一项关于利福平-米诺环素涂层及银-铂-碳浸渍中心静脉导管的前瞻性随机试验。
Crit Care Med. 2006 Mar;34(3):668-75. doi: 10.1097/01.CCM.0000201404.05523.34.
9
Comparison of silver-impregnated with standard multi-lumen central venous catheters in critically ill patients.危重症患者中银浸渍多腔中心静脉导管与标准多腔中心静脉导管的比较。
Crit Care Med. 2007 Apr;35(4):1032-9. doi: 10.1097/01.CCM.0000259378.53166.1B.
10
Central venous catheter colonization and catheter-related bloodstream infections in critically ill patients: a comparison between standard and silver-integrated catheters.危重症患者中心静脉导管定植和导管相关血流感染:标准导管与含银导管的比较。
Eur J Anaesthesiol. 2009 Sep;26(9):752-8. doi: 10.1097/EJA.0b013e32832a3a84.

引用本文的文献

1
Near-infrared light devices versus landmark approach for peripheral venous access in the intensive care unit: protocol of a randomised controlled study.重症监护病房中近红外光设备与体表标志法用于外周静脉穿刺的比较:一项随机对照研究方案
BMJ Open. 2025 Aug 18;15(8):e102390. doi: 10.1136/bmjopen-2025-102390.
2
Degradable water-soluble polymer prodrugs for subcutaneous delivery of irritant anticancer drugs.用于皮下递送刺激性抗癌药物的可降解水溶性聚合物前药。
Chem Sci. 2025 Jul 10. doi: 10.1039/d5sc02967h.
3
Prevention and management of complications associated with arterial catheters.
动脉导管相关并发症的预防与管理。
BJA Educ. 2025 May;25(5):173-180. doi: 10.1016/j.bjae.2024.12.003. Epub 2025 Feb 25.
4
Management of diabetic keto-acidosis in adult patients admitted to intensive care unit: an ESICM-endorsed international survey.入住重症监护病房的成年糖尿病酮症酸中毒患者的管理:一项得到欧洲重症监护医学学会认可的国际调查。
Crit Care. 2024 Dec 18;28(1):408. doi: 10.1186/s13054-024-05190-w.
5
Reassessing the need for scheduled replacement of short term central venous catheters: A narrative comprehensive review.重新评估短期中心静脉导管定期更换的必要性:一项叙述性综合综述。
Infect Prev Pract. 2024 Nov 7;6(4):100420. doi: 10.1016/j.infpip.2024.100420. eCollection 2024 Dec.
6
FDA announces recall of over 300 000 arrow radial artery catheterization kits: a call for action - an editorial.美国食品药品监督管理局宣布召回超过30万套桡动脉导管插入术套件:行动呼吁——一篇社论
Ann Med Surg (Lond). 2024 Jul 12;86(9):4952-4953. doi: 10.1097/MS9.0000000000002364. eCollection 2024 Sep.
7
Risk factors for arterial catheter failure and complications during critical care hospitalisation: a secondary analysis of a multisite, randomised trial.重症监护住院期间动脉导管失败和并发症的危险因素:一项多中心随机试验的二次分析
J Intensive Care. 2024 Mar 8;12(1):12. doi: 10.1186/s40560-024-00719-1.
8
Clinical factors associated with peripherally inserted central catheters (PICC) related bloodstream infections: a single centre retrospective cohort.与经外周中心静脉置管(PICC)相关血流感染相关的临床因素:单中心回顾性队列研究。
Antimicrob Resist Infect Control. 2023 Jan 30;12(1):5. doi: 10.1186/s13756-023-01209-z.
9
Effectiveness of enhanced check during acute phase to reduce central venous catheters-associated bloodstream infections: a before-after, real-world study.强化急性期中检查以降低中心静脉导管相关血流感染的效果:一项前后对照、真实世界研究。
Antimicrob Resist Infect Control. 2022 Dec 6;11(1):151. doi: 10.1186/s13756-022-01190-z.
10
Epidemiology of ICU-Onset Bloodstream Infection: Prevalence, Pathogens, and Risk Factors Among 150,948 ICU Patients at 85 U.S. Hospitals.ICU 获得性血流感染的流行病学:85 家美国医院 150948 例 ICU 患者的患病率、病原体和危险因素。
Crit Care Med. 2022 Dec 1;50(12):1725-1736. doi: 10.1097/CCM.0000000000005662. Epub 2022 Oct 3.